Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity - Ballard, P; Yates, JWT; Yang, Z (Clin Cancer Res, 2016)
et al.